Adrienne Farid
Operationeel Directeur bij CENTURY THERAPEUTICS, INC.
Vermogen: 432 293 $ op 30-04-2024
Profiel
Adrienne Farid is currently the Chief Operations Officer at Century Therapeutics, Inc. She previously worked as a Director at Carisma Therapeutics, Inc., VP-Project Leadership at Celgene Corp., and Global Head-Project & Portfolio Management at Roche Pharmaceuticals, Inc. Farid holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
03-05-2024 | 137 236 ( 0.21% ) | 432 293 $ | 30-04-2024 |
Actieve functies van Adrienne Farid
Bedrijven | Functie | Begin |
---|---|---|
CENTURY THERAPEUTICS, INC. | Operationeel Directeur | 01-04-2021 |
Eerdere bekende functies van Adrienne Farid
Bedrijven | Functie | Einde |
---|---|---|
CELGENE | Corporate Officer/Principal | 01-07-2017 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01-01-2011 |
CARISMA THERAPEUTICS, INC. | Directeur/Bestuurslid | - |
Opleiding van Adrienne Farid
Barnard College | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CENTURY THERAPEUTICS, INC. | Health Technology |
CARISMA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |